Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Diabetes

Date Submitted: Feb 7, 2026
Date Accepted: Aug 19, 2026

The final, peer-reviewed published version of this preprint can be found here:

An eHealth-Delivered Total Diet Replacement Intervention for Type 2 Diabetes Remission: Single-Arm Pilot Study

Chninou Y, Edholm J, Engvall J, Wahlqvist S, Schien C, Winkvist A, Otten J

An eHealth-Delivered Total Diet Replacement Intervention for Type 2 Diabetes Remission: Single-Arm Pilot Study

JMIR Diabetes 2026;11:e93074

DOI: 10.2196/93074

PMID: 42837539

An eHealth-delivered total diet replacement intervention for type 2 diabetes remission: a single-arm pilot study

  • Youssef Chninou; 
  • Johanned Edholm; 
  • Jenny Engvall; 
  • Sofia Wahlqvist; 
  • Claudia Schien; 
  • Anna Winkvist; 
  • Julia Otten

ABSTRACT

Background:

The DiRECT trial demonstrated that remission of type 2 diabetes can be achieved through substantial weight loss using a total diet replacement intervention combined with structured support. Whether this approach can be delivered exclusively via eHealth has not been well studied.

Objective:

This pilot study aimed to evaluate whether a total diet replacement intervention delivered solely via eHealth could induce clinically meaningful weight loss and achieve type 2 diabetes remission.

Methods:

This was a single-arm, non-blinded, single-center pilot study conducted at the clinical research facilities of Umeå University Hospital. Individuals with type 2 diabetes diagnosed within the past 6 years were included. Participants followed a total diet replacement (~850 kcal/day) for 12 weeks, then gradually reintroduced food, with a total study duration of 6 months. Diabetes medications were discontinued at the start of the study. Daily body weight and fasting glucose were measured at home and transmitted to the study team via connected devices. All clinical support was delivered through video calls and chat. The two primary outcomes were a reduction in weight of 15 kg or more and remission of diabetes, defined as HbA1c <6.5% without glucose-lowering medication, from baseline to 6 months. A 75g oral glucose tolerance test (OGTT) and indirect calorimetry were performed at baseline and at 6 months to assess resting energy expenditure (REE) and respiratory quotient (RQ).

Results:

Ten participants (mean age 58.5 years; mean BMI 35.3 kg/m²; nine male and one female) were enrolled. After 6 months, six of ten participants achieved the primary outcome of ≥15.0 kg weight loss, and all ten participants achieved the primary outcome of diabetes remission and met the prespecified HbA1c-based remission criterion. Mean weight loss was 16.9 ± 5.4 kg (P=.005), and HbA1c decreased by 1.0 ± 0.8 % (P=.008). Daily home measurements showed a marked reduction in fasting glucose within the first week of the intervention. Median REE decreased by 19%, while median fasting RQ and post–glucose-load RQ increased by 16% at 6 months.

Conclusions:

In this pilot study, an eHealth-delivered total diet replacement intervention was associated with substantial weight loss and diabetes remission at 6 months without the use of glucose-lowering medication. These findings support further evaluation of fully eHealth-delivered dietary interventions in larger and longer-term randomized controlled trials. Clinical Trial: ClinicalTrials.gov (NCT4805996)


 Citation

Please cite as:

Chninou Y, Edholm J, Engvall J, Wahlqvist S, Schien C, Winkvist A, Otten J

An eHealth-Delivered Total Diet Replacement Intervention for Type 2 Diabetes Remission: Single-Arm Pilot Study

JMIR Diabetes 2026;11:e93074

DOI: 10.2196/93074

PMID: 42837539

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.